Ketamine Adverse Reaction
7
1
1
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
14.3%
1 terminated out of 7 trials
83.3%
-3.2% vs benchmark
14%
1 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
The Impact of Preoperative Suggestion on Dreaming
Efficacy of Ketamine in Post Anesthesia Recovery Room
Evaluation of Ketamine as Sedative Agent in Endoscopic Retrograde Cholangiopancreatography (ERCP)
Cardiovascular Safety After Continuous Ketamine Infusion
Neuropsychiatric and Cardiovascular Side Effects in Ketamine Analgesic Infusions
Intranasal Ketamine for Pediatric Procedural Sedation: a Feasibility Study
Does a Single Intravenous Dose of Ketamine Reduce the Need for Supplemental Opioids in Post-Cesarean Section Patients?